Skip to main content
. Author manuscript; available in PMC: 2007 Sep 1.
Published in final edited form as: Blood Cells Mol Dis. 2006 Aug 2;37(2):100–106. doi: 10.1016/j.bcmd.2006.06.003

Table 5.

Race specific odds of venous versus arterial thromboembolic events in study participants

Race Predictors retained in the model Odds Ratio [95% CI] p-value
European American Age 1.07 [1.02, 1.12 ] 0.003
(n=89) Gender* 3.57 [1.08, 11.85] 0.037
Income 0.69 [0.37, 1.28 ] 0.24
< High School education 2.50 [0.46, 3.48 ] 0.28
BMI 0.96 [0.89, 1.04] 0.36
Hypercholesterolemia 2.40 [0.56, 10.32] 0.24
Hypertension 0.51 [0.13, 2.01] 0.33
Diabetes 0.93 [0.27, 3.18] 0.91
FVL (GA) mutation 6.35 [1.20, 33.7] 0.030
African American Age 1.09 [1.04, 1.14] <0.0001
(n=105) Gender* 3.92 [1.14, 13.49] 0.03
Income 1.69 [0.87 3.29] 0.12
< High School education 0.28 [0.09, 0.89] 0.032
BMI 1.03 [0.95, 1.11] 0.48
Hypercholesterolemia 0.47 [0.13, 1.63] 0.23
Hypertension 0.58 [0.19, 1.80] 0.35
Diabetes 1.05 [0.34, 3.21] 0.93
FVL (GA) mutation 1.07 [0.05, 24.42] 0.97

Significant p-values bolded

*

Females constitute the referent group for gender comparisons Arterial thromboembolism includes patients with MI, Stroke & TIA. Venous thromboembolism includes patients with DVT & PE.

HHS Vulnerability Disclosure